Global Cancer Biopharmaceuticals Market Insights, Forecast to 2028

  • Report ID:237129
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jun-22
  • No. of Pages: 110
                              
Cancer Biopharmaceuticals market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Biopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Biologics Biosimilars Segment by Application Liquid Cancers Solid Cancers By Company Sanofi Johnson & Johnson Pfizer Novartis Merck GlaxoSmithKline Eli Lilly Agios Pharmaceuticals Bristol-Myers Squibb AstraZeneca Mylan LEO Pharma Boehringer Ingelheim Alexion Pharmaceuticals Elusys Therapeutics By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Biologics 1.2.3 Biosimilars 1.3 Market by Application 1.3.1 Global Cancer Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Liquid Cancers 1.3.3 Solid Cancers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Biopharmaceuticals Market Perspective (2017-2028) 2.2 Cancer Biopharmaceuticals Growth Trends by Region 2.2.1 Cancer Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cancer Biopharmaceuticals Historic Market Size by Region (2017-2022) 2.2.3 Cancer Biopharmaceuticals Forecasted Market Size by Region (2023-2028) 2.3 Cancer Biopharmaceuticals Market Dynamics 2.3.1 Cancer Biopharmaceuticals Industry Trends 2.3.2 Cancer Biopharmaceuticals Market Drivers 2.3.3 Cancer Biopharmaceuticals Market Challenges 2.3.4 Cancer Biopharmaceuticals Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Biopharmaceuticals Players by Revenue 3.1.1 Global Top Cancer Biopharmaceuticals Players by Revenue (2017-2022) 3.1.2 Global Cancer Biopharmaceuticals Revenue Market Share by Players (2017-2022) 3.2 Global Cancer Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cancer Biopharmaceuticals Revenue 3.4 Global Cancer Biopharmaceuticals Market Concentration Ratio 3.4.1 Global Cancer Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopharmaceuticals Revenue in 2021 3.5 Cancer Biopharmaceuticals Key Players Head office and Area Served 3.6 Key Players Cancer Biopharmaceuticals Product Solution and Service 3.7 Date of Enter into Cancer Biopharmaceuticals Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Biopharmaceuticals Breakdown Data by Type 4.1 Global Cancer Biopharmaceuticals Historic Market Size by Type (2017-2022) 4.2 Global Cancer Biopharmaceuticals Forecasted Market Size by Type (2023-2028) 5 Cancer Biopharmaceuticals Breakdown Data by Application 5.1 Global Cancer Biopharmaceuticals Historic Market Size by Application (2017-2022) 5.2 Global Cancer Biopharmaceuticals Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cancer Biopharmaceuticals Market Size (2017-2028) 6.2 North America Cancer Biopharmaceuticals Market Size by Type 6.2.1 North America Cancer Biopharmaceuticals Market Size by Type (2017-2022) 6.2.2 North America Cancer Biopharmaceuticals Market Size by Type (2023-2028) 6.2.3 North America Cancer Biopharmaceuticals Market Share by Type (2017-2028) 6.3 North America Cancer Biopharmaceuticals Market Size by Application 6.3.1 North America Cancer Biopharmaceuticals Market Size by Application (2017-2022) 6.3.2 North America Cancer Biopharmaceuticals Market Size by Application (2023-2028) 6.3.3 North America Cancer Biopharmaceuticals Market Share by Application (2017-2028) 6.4 North America Cancer Biopharmaceuticals Market Size by Country 6.4.1 North America Cancer Biopharmaceuticals Market Size by Country (2017-2022) 6.4.2 North America Cancer Biopharmaceuticals Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Cancer Biopharmaceuticals Market Size (2017-2028) 7.2 Europe Cancer Biopharmaceuticals Market Size by Type 7.2.1 Europe Cancer Biopharmaceuticals Market Size by Type (2017-2022) 7.2.2 Europe Cancer Biopharmaceuticals Market Size by Type (2023-2028) 7.2.3 Europe Cancer Biopharmaceuticals Market Share by Type (2017-2028) 7.3 Europe Cancer Biopharmaceuticals Market Size by Application 7.3.1 Europe Cancer Biopharmaceuticals Market Size by Application (2017-2022) 7.3.2 Europe Cancer Biopharmaceuticals Market Size by Application (2023-2028) 7.3.3 Europe Cancer Biopharmaceuticals Market Share by Application (2017-2028) 7.4 Europe Cancer Biopharmaceuticals Market Size by Country 7.4.1 Europe Cancer Biopharmaceuticals Market Size by Country (2017-2022) 7.4.2 Europe Cancer Biopharmaceuticals Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cancer Biopharmaceuticals Market Size (2017-2028) 8.2 Asia-Pacific Cancer Biopharmaceuticals Market Size by Type 8.2.1 Asia-Pacific Cancer Biopharmaceuticals Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Cancer Biopharmaceuticals Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Cancer Biopharmaceuticals Market Share by Type (2017-2028) 8.3 Asia-Pacific Cancer Biopharmaceuticals Market Size by Application 8.3.1 Asia-Pacific Cancer Biopharmaceuticals Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Cancer Biopharmaceuticals Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Cancer Biopharmaceuticals Market Share by Application (2017-2028) 8.4 Asia-Pacific Cancer Biopharmaceuticals Market Size by Region 8.4.1 Asia-Pacific Cancer Biopharmaceuticals Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Cancer Biopharmaceuticals Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cancer Biopharmaceuticals Market Size (2017-2028) 9.2 Latin America Cancer Biopharmaceuticals Market Size by Type 9.2.1 Latin America Cancer Biopharmaceuticals Market Size by Type (2017-2022) 9.2.2 Latin America Cancer Biopharmaceuticals Market Size by Type (2023-2028) 9.2.3 Latin America Cancer Biopharmaceuticals Market Share by Type (2017-2028) 9.3 Latin America Cancer Biopharmaceuticals Market Size by Application 9.3.1 Latin America Cancer Biopharmaceuticals Market Size by Application (2017-2022) 9.3.2 Latin America Cancer Biopharmaceuticals Market Size by Application (2023-2028) 9.3.3 Latin America Cancer Biopharmaceuticals Market Share by Application (2017-2028) 9.4 Latin America Cancer Biopharmaceuticals Market Size by Country 9.4.1 Latin America Cancer Biopharmaceuticals Market Size by Country (2017-2022) 9.4.2 Latin America Cancer Biopharmaceuticals Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cancer Biopharmaceuticals Market Size (2017-2028) 10.2 Middle East & Africa Cancer Biopharmaceuticals Market Size by Type 10.2.1 Middle East & Africa Cancer Biopharmaceuticals Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Cancer Biopharmaceuticals Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Cancer Biopharmaceuticals Market Share by Type (2017-2028) 10.3 Middle East & Africa Cancer Biopharmaceuticals Market Size by Application 10.3.1 Middle East & Africa Cancer Biopharmaceuticals Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Cancer Biopharmaceuticals Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Cancer Biopharmaceuticals Market Share by Application (2017-2028) 10.4 Middle East & Africa Cancer Biopharmaceuticals Market Size by Country 10.4.1 Middle East & Africa Cancer Biopharmaceuticals Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Cancer Biopharmaceuticals Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Cancer Biopharmaceuticals Introduction 11.1.4 Sanofi Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.1.5 Sanofi Recent Developments 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Cancer Biopharmaceuticals Introduction 11.2.4 Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.2.5 Johnson & Johnson Recent Developments 11.3 Pfizer 11.3.1 Pfizer Company Details 11.3.2 Pfizer Business Overview 11.3.3 Pfizer Cancer Biopharmaceuticals Introduction 11.3.4 Pfizer Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.3.5 Pfizer Recent Developments 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Cancer Biopharmaceuticals Introduction 11.4.4 Novartis Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.4.5 Novartis Recent Developments 11.5 Merck 11.5.1 Merck Company Details 11.5.2 Merck Business Overview 11.5.3 Merck Cancer Biopharmaceuticals Introduction 11.5.4 Merck Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.5.5 Merck Recent Developments 11.6 GlaxoSmithKline 11.6.1 GlaxoSmithKline Company Details 11.6.2 GlaxoSmithKline Business Overview 11.6.3 GlaxoSmithKline Cancer Biopharmaceuticals Introduction 11.6.4 GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.6.5 GlaxoSmithKline Recent Developments 11.7 Eli Lilly 11.7.1 Eli Lilly Company Details 11.7.2 Eli Lilly Business Overview 11.7.3 Eli Lilly Cancer Biopharmaceuticals Introduction 11.7.4 Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.7.5 Eli Lilly Recent Developments 11.8 Agios Pharmaceuticals 11.8.1 Agios Pharmaceuticals Company Details 11.8.2 Agios Pharmaceuticals Business Overview 11.8.3 Agios Pharmaceuticals Cancer Biopharmaceuticals Introduction 11.8.4 Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.8.5 Agios Pharmaceuticals Recent Developments 11.9 Bristol-Myers Squibb 11.9.1 Bristol-Myers Squibb Company Details 11.9.2 Bristol-Myers Squibb Business Overview 11.9.3 Bristol-Myers Squibb Cancer Biopharmaceuticals Introduction 11.9.4 Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.9.5 Bristol-Myers Squibb Recent Developments 11.10 AstraZeneca 11.10.1 AstraZeneca Company Details 11.10.2 AstraZeneca Business Overview 11.10.3 AstraZeneca Cancer Biopharmaceuticals Introduction 11.10.4 AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.10.5 AstraZeneca Recent Developments 11.11 Mylan 11.11.1 Mylan Company Details 11.11.2 Mylan Business Overview 11.11.3 Mylan Cancer Biopharmaceuticals Introduction 11.11.4 Mylan Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.11.5 Mylan Recent Developments 11.12 LEO Pharma 11.12.1 LEO Pharma Company Details 11.12.2 LEO Pharma Business Overview 11.12.3 LEO Pharma Cancer Biopharmaceuticals Introduction 11.12.4 LEO Pharma Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.12.5 LEO Pharma Recent Developments 11.13 Boehringer Ingelheim 11.13.1 Boehringer Ingelheim Company Details 11.13.2 Boehringer Ingelheim Business Overview 11.13.3 Boehringer Ingelheim Cancer Biopharmaceuticals Introduction 11.13.4 Boehringer Ingelheim Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.13.5 Boehringer Ingelheim Recent Developments 11.14 Alexion Pharmaceuticals 11.14.1 Alexion Pharmaceuticals Company Details 11.14.2 Alexion Pharmaceuticals Business Overview 11.14.3 Alexion Pharmaceuticals Cancer Biopharmaceuticals Introduction 11.14.4 Alexion Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.14.5 Alexion Pharmaceuticals Recent Developments 11.15 Elusys Therapeutics 11.15.1 Elusys Therapeutics Company Details 11.15.2 Elusys Therapeutics Business Overview 11.15.3 Elusys Therapeutics Cancer Biopharmaceuticals Introduction 11.15.4 Elusys Therapeutics Revenue in Cancer Biopharmaceuticals Business (2017-2022) 11.15.5 Elusys Therapeutics Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Cancer Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Biologics Table 3. Key Players of Biosimilars Table 4. Global Cancer Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Cancer Biopharmaceuticals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Cancer Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Cancer Biopharmaceuticals Market Share by Region (2017-2022) Table 8. Global Cancer Biopharmaceuticals Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Cancer Biopharmaceuticals Market Share by Region (2023-2028) Table 10. Cancer Biopharmaceuticals Market Trends Table 11. Cancer Biopharmaceuticals Market Drivers Table 12. Cancer Biopharmaceuticals Market Challenges Table 13. Cancer Biopharmaceuticals Market Restraints Table 14. Global Cancer Biopharmaceuticals Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Cancer Biopharmaceuticals Revenue Share by Players (2017-2022) Table 16. Global Top Cancer Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopharmaceuticals as of 2021) Table 17. Ranking of Global Top Cancer Biopharmaceuticals Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Cancer Biopharmaceuticals Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cancer Biopharmaceuticals Product Solution and Service Table 21. Date of Enter into Cancer Biopharmaceuticals Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Cancer Biopharmaceuticals Revenue Market Share by Type (2017-2022) Table 25. Global Cancer Biopharmaceuticals Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Cancer Biopharmaceuticals Revenue Market Share by Type (2023-2028) Table 27. Global Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Cancer Biopharmaceuticals Revenue Share by Application (2017-2022) Table 29. Global Cancer Biopharmaceuticals Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Cancer Biopharmaceuticals Revenue Share by Application (2023-2028) Table 31. North America Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Cancer Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Cancer Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Cancer Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Cancer Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Cancer Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Cancer Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Cancer Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Cancer Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Cancer Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Cancer Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Cancer Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Cancer Biopharmaceuticals Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Cancer Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Cancer Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Cancer Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Cancer Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Cancer Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Cancer Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Cancer Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Cancer Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Cancer Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Cancer Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 61. Sanofi Company Details Table 62. Sanofi Business Overview Table 63. Sanofi Cancer Biopharmaceuticals Product Table 64. Sanofi Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 65. Sanofi Recent Developments Table 66. Johnson & Johnson Company Details Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Cancer Biopharmaceuticals Product Table 69. Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 70. Johnson & Johnson Recent Developments Table 71. Pfizer Company Details Table 72. Pfizer Business Overview Table 73. Pfizer Cancer Biopharmaceuticals Product Table 74. Pfizer Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 75. Pfizer Recent Developments Table 76. Novartis Company Details Table 77. Novartis Business Overview Table 78. Novartis Cancer Biopharmaceuticals Product Table 79. Novartis Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 80. Novartis Recent Developments Table 81. Merck Company Details Table 82. Merck Business Overview Table 83. Merck Cancer Biopharmaceuticals Product Table 84. Merck Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 85. Merck Recent Developments Table 86. GlaxoSmithKline Company Details Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Cancer Biopharmaceuticals Product Table 89. GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 90. GlaxoSmithKline Recent Developments Table 91. Eli Lilly Company Details Table 92. Eli Lilly Business Overview Table 93. Eli Lilly Cancer Biopharmaceuticals Product Table 94. Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 95. Eli Lilly Recent Developments Table 96. Agios Pharmaceuticals Company Details Table 97. Agios Pharmaceuticals Business Overview Table 98. Agios Pharmaceuticals Cancer Biopharmaceuticals Product Table 99. Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 100. Agios Pharmaceuticals Recent Developments Table 101. Bristol-Myers Squibb Company Details Table 102. Bristol-Myers Squibb Business Overview Table 103. Bristol-Myers Squibb Cancer Biopharmaceuticals Product Table 104. Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 105. Bristol-Myers Squibb Recent Developments Table 106. AstraZeneca Company Details Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Cancer Biopharmaceuticals Product Table 109. AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 110. AstraZeneca Recent Developments Table 111. Mylan Company Details Table 112. Mylan Business Overview Table 113. Mylan Cancer Biopharmaceuticals Product Table 114. Mylan Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 115. Mylan Recent Developments Table 116. LEO Pharma Company Details Table 117. LEO Pharma Business Overview Table 118. LEO Pharma Cancer Biopharmaceuticals Product Table 119. LEO Pharma Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 120. LEO Pharma Recent Developments Table 121. Boehringer Ingelheim Company Details Table 122. Boehringer Ingelheim Business Overview Table 123. Boehringer Ingelheim Cancer Biopharmaceuticals Product Table 124. Boehringer Ingelheim Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 125. Boehringer Ingelheim Recent Developments Table 126. Alexion Pharmaceuticals Company Details Table 127. Alexion Pharmaceuticals Business Overview Table 128. Alexion Pharmaceuticals Cancer Biopharmaceuticals Product Table 129. Alexion Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 130. Alexion Pharmaceuticals Recent Developments Table 131. Elusys Therapeutics Company Details Table 132. Elusys Therapeutics Business Overview Table 133. Elusys Therapeutics Cancer Biopharmaceuticals Product Table 134. Elusys Therapeutics Revenue in Cancer Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 135. Elusys Therapeutics Recent Developments Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Biopharmaceuticals Market Share by Type: 2021 VS 2028 Figure 2. Biologics Features Figure 3. Biosimilars Features Figure 4. Global Cancer Biopharmaceuticals Market Share by Application: 2021 VS 2028 Figure 5. Liquid Cancers Case Studies Figure 6. Solid Cancers Case Studies Figure 7. Cancer Biopharmaceuticals Report Years Considered Figure 8. Global Cancer Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Cancer Biopharmaceuticals Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Cancer Biopharmaceuticals Market Share by Region: 2021 VS 2028 Figure 11. Global Cancer Biopharmaceuticals Market Share by Players in 2021 Figure 12. Global Top Cancer Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biopharmaceuticals as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Cancer Biopharmaceuticals Revenue in 2021 Figure 14. North America Cancer Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Cancer Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 16. North America Cancer Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 17. North America Cancer Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 18. United States Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Cancer Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Cancer Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 22. Europe Cancer Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 23. Europe Cancer Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 24. Germany Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Cancer Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Cancer Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Cancer Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Cancer Biopharmaceuticals Market Size Share by Region (2017-2028) Figure 34. China Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Cancer Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Cancer Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 42. Latin America Cancer Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 43. Latin America Cancer Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 44. Mexico Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Cancer Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Cancer Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Cancer Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Cancer Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 50. Turkey Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Cancer Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Sanofi Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 55. Pfizer Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 56. Novartis Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 57. Merck Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 58. GlaxoSmithKline Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 59. Eli Lilly Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 60. Agios Pharmaceuticals Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 62. AstraZeneca Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 63. Mylan Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 64. LEO Pharma Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 65. Boehringer Ingelheim Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 66. Alexion Pharmaceuticals Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 67. Elusys Therapeutics Revenue Growth Rate in Cancer Biopharmaceuticals Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.